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Abstract.  Our previous studies showed that the txsB~ 
integrin selects cysteine pair-containing RGD peptides 
from a phage display library based on a random hexa- 
peptide. We have therefore searched for more selec- 
tive peptides for this integrin using a larger phage 
display library, where heptapeptides are flanked by 
cysteine residues, thus making the inserts potentially 
cyclic. Most of the phage sequences that bound to 
OL5/31 (69 of 125) contained the RGD motif. Some of 
the heptapeptides contained an NGR motif. As the 
NGR sequence occurs in the cell-binding region of the 
fibronectin molecule, this sequence could contribute to 
the specific recognition of fibronectin by a5/31. Selec- 
tion for high affinity peptides for o~5/31 surprisingly 
yielded a sequence RRETAWA that does not bear ob- 
vious resemblance to known integrin ligand se- 
quences. The synthetic cyclic peptide GACR- 
RETAWACGA (*CRRETAWAC*) was a potent in- 
hibitor of c~5/31-mediated  cell attachment to fibronectin. 
This peptide is nearly specific for the usB~ integrin, 
because much higher concentrations were needed to 
inhibit the Uv#~ integrin, and there was no effect on 
ot,/33- and ot,/35-mediated cell attachment to vitronectin. 
The peptide also did not bind to the otmfl3 integrin. 
*CRRETAWAC* appears to interact with the same or 
an overlapping binding site in t~5/31 as RGD, because 
cell attachment to *CRRETAWAC* coated on plastic 
was divalent cation dependent and could be blocked 
by an RGD-contalning peptide. These results reveal a 
novel binding specificity in the usBl integrin. 
F 
mRONECTiN is the only known protein ligand for the 
cts~ integrin (Pytela et al.,  1985). This binding  is 
mediated by the RGD sequence in the 10th type III 
repeat of fibronectin (Pierschbacher and Ruoslahti,  1984). 
Studies with mutated forms of fibronectin have suggested 
that regions in the 8th and 9th type III repeats are also needed 
for the full adhesive activity of fibronectin  (Obara  et al., 
1988; Aota et al.,  1991; Nagai et al.,  1991). These syner- 
gistically acting regions may contribute to the specific rec- 
ognition of fibronectin by OtsB~. 
The ot5/3~ integrin is important in promoting the assembly 
of  fibronectin  matrix  and  initiating  cell  attachment  to 
fibronectin  (Akiyama et al.,  1989; Zhang et al.,  1993). 
Moreover,  o~5/~1 also appears  to play crucial roles  in cell 
migration (Bauer et al., 1992, 1993; Zhang et al., 1993) as 
well as tumor invasion and metastasis (Gehlsen et al., 1988; 
Humphries et al.,  1986; Saiki et al.,  1989; Seftor et al., 
1993). Probing of Otsfl~ function with RGD-containing pep- 
tides has suffered from the drawback that these peptides also 
bind to several other integrins  such as the av~3 and a,B5 
vitronectin receptors and the Ot~rd~3 fibrinogen receptor of 
platelets  (Ruoslahti and Pierschbacher,  1987). 
Peptide libraries (Smith and Scott,  1993) offer a way of 
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searching for peptides with improved binding affinities and 
selectivities  for  integrins.  In  previous  experiments,  we 
searched for peptides binding to aSBl from a hexapeptide li- 
brary expressed on the surface of filamentous phage (Koivu- 
nen et al.,  1993). Among the several phage sequences that 
bound to asB~ was the cyclic peptide  GA*CRGDC*LGA. 
This  peptide,  while not specific  for asBl,  has  a  10-fold 
higher affinity for otsBt than the standard linear RGD pep- 
tides such as GRGDSP. 
The hexapeptide library, even though capable of present- 
ing peptides containing disulfide bonds, seemed to have only 
a limited repertoire of such peptides.  We, therefore,  con- 
structed a heptapeptide library in which a random heptapep- 
tide insert is flanked by a cysteine residue on each side. A 
disulfide bond formed by the cysteines cyclized the random 
sequences,  and as a result the library expresses conforma- 
tionally constrained peptides capable of high-affinity inter- 
actions with receptors.  Potent ligands for the o~r~3 integrin 
have been isolated from such a library based on a cyclic hexa- 
peptide (O'Neil et al.,  1992). We describe here novel O¢sB~- 
binding  sequences  selected from the  cyclic heptapeptide 
library. 
Materials and Methods 
Materials 
The fUSE 5 virions (Scott and Smith,  1990) and Escherichia  cold strains 
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Dr.  G.  Smith (University of Missouri,  Columbia,  MO).  Human plasma 
fibronectin was from the Finnish Red Cross and was iodinated as described 
(Morla and Ruoslahti,  1992). A  ll0-kD fragment of fibronectin was pre- 
pared as previously described (Pierschbacher et al.,  1981). Vitronectin was 
purified  from  human  plasma  as  described  (Yatohgo  et  al.,  1988). 
Glutaraldehyde was from Sigma Immunochemicals (St. Louis, MO). Pep- 
tides were synthesized on a Applied Biosystems model 430A synthesizer 
(Foster City, CA) by standard Merrifield solid phase synthesis protocols and 
t-butoxycarbonyl chemistry. Peptides were cyclized by oxidizing with 0.01 M 
KaFe(CN)6 at pH 8.4 and purified by reverse-phase HPLC.  To relinearize 
cyclic peptides, the disulfide bond was reduced and alkylated as described 
(Koivunen et al.,  1993). 
The av~3 integrin was isolated from human placental extracts made in 
TBS buffer containing 0.1 M octyl glucoside, 1 mM MnC12,  1 mM CaC12, 
and proteinase inhibitors (Pytela et al.,  1987). The t~s~l integrin was iso- 
lated  from the same extract using immunoaffinity chromatography  with 
polyclonal antibodies against the cytoplasmic tall of c~5 subunit (Giancotti 
and Ruoslahti,  1990). cts/~l bound to the affinity column was eluted with 
0.1 mg/mi of the immunizing cytoplasmic tail peptide (Giancotti and Ruos- 
lahti, 1990) in TBS buffer containing 25 mM octyl glucoside. The integrin 
was purified further using wheat germ agglutinin-Sepharose as described 
(Pytela et al.,  1987). The CqlbB3 integrin was isolated from ontdated plate- 
lets (Pytela et al.,  1986). 
Construction of Heptapeptide Library 
A beptapeptide library displaying cyclic sequences was constructed on fUSE 
5 vector essentially as described (Scott and Smith, 1990). The peptides are 
expressed at the NH2 terminus of phage surface protein III in this vector. 
Single stranded DNA was prepared from fUSE 5 virions and transfected into 
K802 cells by electroporation. Double-stranded fuse 5 DNA was extracted 
from K802 cells with a plasmid preparation kit (Qiagen Inc., Chatsworth, 
CA) and further purified by CsC1 density gradient centrifugation. The insert 
was prepared by polymerase chain reaction amplification and BglI digestion 
from synthetic oligonucleotide (Scott and Smith,  1990) that contained a 
core sequence TGT(NNK)7TGT (N =  equal molar mixture of A, C, G, T; 
K =  G or T). The degenerate oligonucleotide was purified from 15% poly- 
acrylamide gel and ligated to fUSE 5 vector previously cleaved with SfiI. 
About 24 ~g of the ligated vector was transformed into MC1061  ceils by 
263 separate electroporations with BRL electroporator and booster accord- 
ing to the instructions of the manufacturer (GIBCO-BRL,  Gaithersburg, 
MD). After culturing the bacteria for 24 h, phage were prepared from 3.2 
liter of culture medium by precipitating twice with polyethylene glycol. The 
procedure  yielded  a  primary  library  containing 4.5  ×  109 clones.  Se- 
quencing of DNA extracted from a small aliquot of the library indicated the 
expected distribution of bases. 
Selection of ~{31-binding Phage 
An aliquot of the library containing 2.5  ×  1012 transducing units (TU) 1 
was screened with t~s/~l coated on microtiter wells as described (Koivunen 
et al.,  1993). In the first and second panning the coating concentration of 
the integrin was 5/~g/well. To increase the stringency of the panning, the 
wells were coated with decreasing concentrations of the integrin.  Phage 
were selected for further amplification from the well with the lowest integrin 
concentration that showed phage binding over background. In the third and 
fourth panning, the concentrations were 10 and 1 ng/well, respectively. To 
rescue the bound phage, the wells were elnted with a 0.1 M glycine buffer, 
pH 2.2, containing 1 mg/ml bovine serum albumin and 0.1 mg/ml of phenol 
red.  Phage were sequenced from randomly selected clones as described 
(Koivunen et al.,  1993). 
Phage Attachment Assay 
Binding of individual cloned phage to integrins was studied essentially as 
described (Koivunen et al.,  1993) except that the entire assay was done in 
microtiter wells. Phage were incubated for 1 h at room temperature in mi- 
crotiter wells coated with t~s/31 or ctv/~3. The wells were washed five times 
and 20 ttl of concentrated K91kan bacteria (Smith and Scott, 1993), diluted 
1. Abbreviations  used in this paper:  *CRGDC*,  cyclic GACRGDCLGA 
peptide;  *CRRETAWAC*,  cyclic GACRRETAWACGA  peptide;  ICs0, 
half-maximal inhibitory concentration; TU, transducting unit. 
1:5 in Terrific broth media (Sambrook et al., 1989), was added into the wells 
and incubated for 10 min at 37°C. After adding 100/zl of Terrific broth con- 
taming 0.2 #g/ml of tetracycline and 100 ~g/ml of kanamycin, the incuba- 
tion was continued for an additional 30 min at 37°C.  Another 100 tzl of 
Terrific broth containing 50 #g/ml of tetracycline and 100 ttg/ml of kanamy- 
cin was added and the microtiter plate was incubated at room temperature 
overnight with shaking. The absorbance indicative of bacterial growth was 
read at 600 nm with an ELISA reader. 
Fibronectin-binding Assay 
The binding of 1251-labeled fibronectin to as~t coated on plastic was per- 
formed as described (Koivunen et al.,  1993). 
Cell Attachment Assay 
Cell lines expressing different integrins were used in cell attachment assays 
to examine peptide inhibition of integfin function. A human melanoma cell 
line C8161 (Seftor et al.,  1993), a fibroblast cell line WI-38 (Vogel et al., 
1990), and an osteosarcoma cell line MG-63 (Pytela et al.,  1985) attach 
to fibronectin through the cxs/31 integrin, as do B2/a27,  a CHO cell line 
transfected with human ~5,  and B2/C1,  the  control parental  CHO  line 
(Bauer et al., 1992). CHO cells C11 and NIH 3T3 cells express the endoge- 
nous Chinese hamster and mouse as/~ integrins (Solowska et al.,  1989; 
Giancotti and Ruoslahti, 1990). The human melanoma cells A375-M attach 
to fibronectin through both the c~s/31 and a4/~1 integrins (Mould et al., 
1990). The uv/~l integrin-expressing cell line studied was a CHO cell line 
B2/v7  (Zhang et al.,  1993).  The vitronectin-binding integrins ctv/~s and 
~/~3 were assayed using the cell lines HT-29  and IMR-90,  respectively 
(Koivunen et al., 1993). Microtiter wells were coated with various concen- 
trations of fibronectin or vitronectin. In some assays fixed concentrations 
that resulted in 60% maximum attachment for the test cells were used. Pep- 
tide  was  coated  on plastic by incubating for 2  h  at 37"C  in phosphate 
buffered saline containing 0.25%  glutaraldehyde to crosslink the peptide. 
Any free binding sites on plastic were blocked with bovine serum albumin. 
Approximately 1 ×  105 cells per well were allowed to attach for 1 h in the 
presence or absence of competing poptides and the bound cells were deter- 
mined by staining with 0.1%  amido black (Ruoslahti et al.,  1982). 
Results 
Phage Selected by ~j[31 Integrin Binding Display RGD 
and NGR Motifs 
A majority  (69 of 125) of the phage bound to t~s/~ from the 
cyclic heptapeptide library  contained the RGD sequence in 
the insert (Table I). The RGD sequences were found in three 
positions  of the  heptapeptide,  in  the  middle,  next  to  the 
NH~-terminal  cysteine, or one residue removed from it. Se- 
lection of high affinity clones by decreasing the coating con- 
centration of ots/~l-favored clones  that contained  a  glycine 
residue after RGD.  Moreover, the glycine was followed by 
an aromatic  residue, tryptophan  or phenylalanine,  in those 
sequences. No enrichment of any particular amino acids was 
noted at the positions preceding the RGD. 
Another o~5/~-binding motif detected was the RGD ana- 
logue NGR,  and its variation,  NGH (Table H).  NGR was 
found  in  eight  peptides.  One  NGR-containing  clone  dis- 
played a sequence VLNGRME which is quite similar to the 
sequence ALNGREE present in the 9th type III repeat of hu- 
man  fibronectin  (Kornblihtt  et  ai.,  1985).  The  sequence 
ASVNGHT in which the arginine of NGR was replaced by 
histidine was detected in four clones. 
Other Non-RGD-type Sequences 
The other ot~/~l-binding non-RGD sequences derived from 
the cyclic heptapeptide library were more heterogeneous, 
but could be classified into five groups (Table II). Represen- 
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Integrin coating concentration  for plastic 
50,000 ng/ml  1,000 ng/ml  100 ng/ml  10 ng/ml  10 ng/ml  1 ng/ml 
(2nd panning)  (3rd panning)  (3rd panning)  (4th panning)  (5th panning)  (5th panning) 
LSRGDTP  I PRGDGW  (5)  I PRGDGW (3)  ELRGDGW  (2)  I PRGDGW  (2)  I PRGDGW 
DRRGDG F  RSRGDF P  YRRGDGH  EYRGDG F  VARGDGW  MTRGDG F 
FTRGDAP  VARGDGW  E LRGDGW  VARGDGW  QTRGDGW  L FRGDGW 
TSRGDMP  TRGDGWF  (3)  VARGDGW  LFRGDGW  RGDGFGS 
QLRGDGW  FRGDGFK (2)  TRGDGWF  (3)  LSRGDGW 
EGRGDWH  FRGDFPE  ERGDLRM (2)  FRGDGFV 
TLRGDNH  RRGDGWE  TRGDMQW  RGDGFGS 
H LRGDGW  RGDWPNY  SRGDGW I 
MLRGDSF  LRGDGFL 
MPRGDGF  YRGDHLL 
SRGDGFS (2)  LRGDARF 
FRGDHVR  TRGDGWP 
GRGDSVP  GRGDRPQ 
SRGDG FR  KRGDG FW 
GRGDNLP  RGDFSYM 
RGDLRFN 
Selection and sequencing of phage bound to the a5/3~ integrin  were performed  as described  in Materials  and Methods. The number of clones encoding  the same 
peptide is shown in parentheses. 
tatives of four of these were only present in the initial steps 
of screening and were eliminated in the high affinity screen- 
ing steps. They each appeared to have some degree of homol- 
ogy to sequences from the type III repeats in the cell-binding 
region of fibronectin (Kornblihtt et al.,  1985).  One group 
contained two serines and a  basic residue, a  structure that 
is analogous to the sequence VPGSKST in the 10th type III 
repeat of fibronectin (Table II). Two phage sequences in this 
group contained arginine and asparagine residues; they may 
be homologous to the VPHSRNS  sequence in the 9th type 
HI repeat.  The third group consisted of heterogeneous  se- 
quences that had a serine or phenylalanine residue or both; 
many of these sequences were hydrophobic. This structure 
appears to resemble the ANSFTVH sequence of the 9th type 
III repeat. We also found one sequence resembling the LVD 
motif of fibronectin that is recognized by the et4/3~ (Mould 
et al.,  1991).  That sequence,  STSDVGG,  is similar to the 
EILDVPST sequence of the alternatively spliced CS1 region 
and TVSDVPR  sequence of the  10th type III repeat. 
To determine the relative affinity of the novel non-RGD se- 
quences toward ot5/31, we studied the attachment of individ- 
ual phage clones to microtiter wells coated with t~5/3t. The 
phage clones displaying the peptides VFSIAHE, VRLNSLA, 
TLVPSRS and STSDVGG each bound to ~ts/3t significantly 
over the background (not shown). However, their avidity was 
severalfold  lower  than  that  of  RGD  or  NGR-containing 
Table II.  Non-RGD Sequences  in CXTC Phage Bound to tx~(31 and Their  Comparison  to Fibronectin  Sequences 
Type III 
repe~ 
9th  TGLDSPT  ANSFTVH  VPHSRNS  ALNGREESP 
l~h  TVSDVPR  PTSLLIS  VPGSKST  AVTGRGDSP 
Phage  STSDVGG  (3)  LNTNLGF  (2)  EIVKSSS  WANGRSH  (3)  RRETAWA  (15) 
sequences  PELFVES  GPCSGKS  FVNGRSF (2)  RGAPRAW 
FAGSLLV  NLTLSVS  FANGRHS 
RFGSHVP  TLVPSRS  VLNGRME 
SRPSTFE  YVNGRVS 
SVANSVV  VRLNSLA (2)  WLNGRIN 
ASFFAVQ  VNVEYRN  MANGRLL 
HVLASAF  LNGRGLM 
VFSIAHE  ASVNGHT  (4) 
LVASMTP 
IGTFHHN 
AFYQGLP 
QNAFGYS 
LGEFAFA 
Phage bound to the cts/3~ integrin  were isolated  as described  in Materials  and Methods. The amino acid residues  that are common in each group are highlighted 
by bold. The number of sequences encoding  the same peptide  is indicated  in parentheses. The fibronectin  sequences are shown in the order as they occur in type 
III repeats, from NH2-terminus to COOH terminus. The sequences at analogous  positions  of the 9th and 10th repeats are aligned.  The residues  underlined show 
homology to phage sequences. 
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Figure 1. Inhibition of binding of RRETAWA-displaying  phage to 
asB~ integrin by RRETAWA and RGD-containing  peptides. Phage 
carrying the insert RRETAWA  (10 n  TU/well)  were incubated  for 
1 h  in the presence of various concentrations of the cyclic peptides 
*CRRETAWAC* and *CRGDC* in microtiter wells coated with the 
as/~  integrin and the phage remaining bound were quantitated as 
described  in Materials  and Methods.  The data show means  from 
duplicate  wells. 
phage, indicating that the sequences have a low affinity to- 
wards  o~5~1. 
A  Novel High-aJ~nity Peptide Ligandfor oo~ 
Surprisingly, the most common sequence detected after the 
high affinity selection was not an RGD peptide but a peptide 
with a sequence RRETAWA. The RRETAWA sequence was 
progressively  enriched  when  the  binding  conditions  for 
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Figure 3.  Effect of *CRRETAWAC*  and *CRGDC*  peptides on 
binding  of  RGD-displaying  phage  to  c~vfls integrin.  The  cyclic 
peptides *CRRETAWAC* and *CRGDC* were allowed to compete 
for the attachment of *CRGDC*-phage  to the o~vfls integrin coated 
on microtiter wells and phage binding was measured as in Fig.  1. 
The data show means  from duplicate  wells. 
phage were made more stringent by decreasing the amount 
of integrin available on plastic. The sequence was detected 
in 4 of 38,  1 of 7, and 10 of 25 total sequences obtained in 
the third, fourth, and fifth pannings, respectively. The same 
nucleotide insert encoded the peptide, suggesting a clonal 
origin. 
We synthesized the cyclic peptide GACRRETAWACGA 
(*CRRETAWAC*) and compared its activity to GA*CRGDC- 
*LGA (*CRGDC*) that had thus far been the most avid pep- 
tide binder of asB1 (Koivunen et al.,  1993).  *CRRETA- 
| 
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0.5 
k_ 
{  "~""'O,  ----O---  *CRRETAWAC* 
I  "c GDc" 
0.4 
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0.1  ........ ,  ....... ~  ....... ~  ....... ~  ........ ,  ....... 
0  .01  .1  1  10  100  1000 
Peptide (l.tM) 
Figure 2.  Inhibition of binding of R(3D-displaying  phage to (~$fll 
integrin by RRETAWA and RGD-containing peptides. Phage carry- 
ing the insert *CRGDC*  (1011 TU/well) were added together with 
various concentrations of the cyclic peptides  *CRRETAWAC*  and 
*CRGDC*  into microtiter wells coated with the (xsBt  integrin and 
phage binding was measured as in Fig.  1. The data represent means 
from duplicate  wells. 
16000: 
14000" 
12000 
10000 
8000 
6000 
4000 
2000 
0 
.01  .1  1  10  100  1000 
Peptide (~tM) 
Figure 4.  Inhibition of binding of 125I-labeled fibronectin to ces/~1 
integrin,  t25I-labeled fibronectin was incubated for 1 h  in the pres- 
ence  of competing  peptides  in  microtiter  wells  coated  with  the 
czsBi integrin.  The wells were washed four times and the radioac- 
tivity remaining bound was measured.  The data represent means 
from duplicate  wells. 
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to tXsBt 10-fold better than  *CRGDC*  (Fig.  1).  A  control 
peptide  GRGESP had  no  effect (not  shown).  *CRRETA- 
WAC* also inhibited the binding of *CRGDC*-containing 
phage to c~5/3t, but in this assay the *CRGDC* peptide was 
a better inhibitor than *CRRETAWAC* (Fig. 2). In contrast, 
the binding of *CRGDC*-containing  phage to the otv/53 in- 
tegrin could not by inhibited by *CRRETAWAC*  (Fig.  3). 
Consistent with this result, the phage displaying RRETAWA 
bound only weakly to microtiter  wells coated with  ~XvB3, 
whereas it bound avidly to oe5/31 under the same conditions. 
RRETAWA-phage also did not bind to wells coated with the 
RGD-directed integrin ct~B3 (not shown). 
The *CRRETAWAC* peptide inhibited the binding of fibro- 
nectin to a5/3~ (Fig.  4).  Half maximal  inhibition  (ICso) for 
both the *CRRETAWAC*  and *CRGDC* peptide was seen 
at 8  x  10  -9 M. We also synthesized and tested one NGR- 
containing peptide A*CVLNGRMEC*G. This sequence was 
selected because of its similarity to the fibronectin sequence. 
The NGR-containing  peptide with an ICso of 2  x  10  -7 M 
was clearly less active than  *CRRETAWAC*  or *CRGDC* 
(Fig. 4). However, this cyclic NGR peptide was a much more 
potent  binder  of otsB1 than  the  linear  peptide  NGRAHA 
(Koivunen  et  al.,  1993).  An  unrelated  cyclic  peptide, 
GA*CSPYFLRLC*GA, used as a control had no significant 
effect. 
The *CRRETAWAC* Peptide Inhibits Cell Attachment 
to lqbronectin 
The  high  potency  and  specificity  of *CRRETAWAC*  for 
¢x5/51 inferred  from  the  integrin-binding  assays  was  con- 
firmed by results from cell attachment  assays.  *CRRETA- 
WAC* inhibited o~5/31-mediated cell attachment  to fibronec- 
tin at an ICso of 3  x  l0  -5 M,  showing similar or slightly 
higher potency than the *CRGDC* peptide. A control pep- 
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Figure 5.  Effect of *CRRETAWAC* peptide on cell attachment to fibronectin and vitronectin. A, B2/tx27 cells (ct5/51); B, B2/v7 cells 
(~XvB0; C, IMR-90 cells (tXv/33); D,  HT-29 cells (c~v/55). Cells were allowed to attach for 1 h  in microtiter wells coated with fibronectin 
(A and B) or vitronectin (C and D). The cells that attached were counted as described in Materials and Methods. The data represent means 
from duplicate wells. 
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a CHO cell line (B2/ct27) that expresses the human or5 sub- 
unit from transfected cDNA (Bauer et al., 1992). Similar re- 
suits were obtained with other txs/31-expressing human cell 
lines studied, C8161, MG-63, and WI-38. The attachment of 
A375-M cells was only partially inhibited by *CRRETAWAC* 
possibly, because this cell line expresses other fibronectin- 
binding integrins, including c~4fl~ (Mould et al.,  1990).  The 
*CRRETAWAC* peptide also blocked cell attachment to a 
110-kD fragment of fibronectin that contains the cell-attach- 
ment domain (not shown).  Surprisingly,  *CRRETAWAC* 
could not block the attachment of CHO Cll ceils or mouse 
NIH 3T3 to fibronectin (not shown), indicating that the pep- 
tide may be species specific.  The disulfide bond was impor- 
tant for the activity of *CRRETAWAC* as reduction and 
alkylation of the peptide decreased its activity about 50-fold 
(not shown). The GACRRETAWACGA peptide that was not 
cyclized by oxidation also had a reduced activity. 
*CRRETAWAC* inhibited o~v~l-mediated cell attachment 
to fibronectin, but high concentrations were needed and its 
activity was more than 100-fold lower than that of*CRGDC* 
(Fig. 5 B).  *CRRETAWAC* showed no inhibition of av/$3- 
or otd3s-mediated cell attachment to vitronectin, whereas 
these interactions were readily inhibited by the *CRGDC* 
peptide (Fig. 5,  C and D). 
Cell lines expressing the o~5/~1 integrin attached onto plas- 
tic coated with the *CRRETAWAC* peptide (Fig. 6).  The 
ct~/3rexpressing cells also bound, but to a lesser extent (re- 
sult not shown). A peptide-coating concentration of 1 mg/ml 
was needed to produce significant attachment, confirming 
the weaker interaction of *CRRETAWAC* with otv/3~ than 
with oa~ indicated by the cell attachment inhibition results 
presented above.  In contrast, cell lines that do not express 
these integrins (CHO-B2/C1,  HT 29) or express nonhuman 
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Figure 6.  Binding of t~s/~l-expressing cells to *CRRETAWAC* 
peptide coated on plastic. B2/c~27 cells were incubated for 1 h in 
microtiter  wells coated  with  various concentrations  of  the 
*CRRETAWAC* peptide. The soluble competing  peptides or EDTA 
were added at the concentrations indicated. The cells that attached 
were quantitated as described in Materials and Methods. The data 
represent means from duplicate wells. 
o~s/3~ (CHO Cll) did not attach to immobilized *CRRETA- 
WAC* (not shown). The cell attachment to *CRRETAWAC* 
was inhibited by the soluble *CRRETAWAC* and *CRGDC* 
peptides, and also by EDTA. 
Discussion 
Our screening of a phage display library that was designed 
to express a random heptapeptide sequence flanked on each 
side by cysteine residues has resulted in the isolation of a 
number of new o~s~t-binding peptides.  These include the 
heterogeneous  group  of  non-RGD-containing  sequences 
that may be homologous to sequences present in the cell- 
binding region of fibronectin. Our results also define the first 
specific peptide ligand for o~513~. 
The  results  presented  here  indicate  that  the  peptides 
selected from the cyclic heptapeptide library for binding to 
a513~ are  more variable than those selected from a  linear 
hexapeptide library. With only a few exceptions, the peptides 
derived from the linear hexapeptide library we used earlier 
were RGD peptides independent of whether the phage were 
eluted by RGD-containing peptide,  EDTA,  or  a  low pH 
buffer (Koivunen et al., 1993). In the present study, we con- 
sistently used a low pH buffer as an elution method to not 
omit any tight binding phage. That many cxslS~-binding non- 
RGD sequences were found in the present study is apparently 
due to the longer insert in the present library and, more im- 
portantly, the cyclic structure of the peptides displayed by it. 
Conformationally constrained peptides are known to have 
an improved affinity for integrins (Pierschbacher and Ruos- 
lahti,  1987; Samanen et al.,  1991; Cardarelli et al.,  1992; 
Gurrath et al,,  1992; Imura et al.,  1992).  The importance 
of  the disulfide bond in the sequences we isolated is indicated 
by the fact that the activity of *CRRETAWAC* peptide was 
greatly diminished after reduction of the disulfide bond and 
alkylation of the cysteines. The NGR sequence also had a 
higher activity when presented in a cyclic peptide. Peptides 
containing a cysteine pair can also appear in high affinity 
screens of the linear peptide library (Koivunen et al., 1993). 
These results and those of O'Neil et al. (1992) suggest that 
peptides containing two cysteines, when fused to the NH2- 
terminus of phage protein III are capable of forming the ex- 
pected disulfide bridge and that the presence of such a bond 
can  greatly  enhance  the  integrin-binding  activity of the 
peptide. 
O'Neil et al. (1992) used a CX6C library to isolate cyclic 
hexapeptides to  the  o~33  platelet integrin and found se- 
quences that contained either the RGD or KGD motif. The 
number of sequences described is small, but there are some 
notable differences as compared to the RGD sequences we 
selected for the cql3~ integrin.  First,  we did not see any 
KGD sequences among the cxsl3~-binding clones.  That se- 
quence is known to bind only to the oL~r~33 integrin and is 
found in some snake venoms (Scarborough et al.,  1991). 
Second, the residue COOH-terminal to RGD often was a 
large  hydrophobic  one  in  the  c~rbinding  sequences, 
whereas we found a strong preference for a glycine residue 
in the c~5~3t-binding clones. The glycine was followed by an 
aromatic tryptophan or phenylalanine. Our recent studies 
with CX6C and CXsC libraries have similarly indicated that 
the  sequence RGDGW/F is  highly enriched in the  ~5/3t- 
binding phage (our unpublished results). These results show 
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ences in the binding specificities of related  integrins. 
The  ots/3~-binding sequences  that  did  not  contain  the 
RGD,  NGR, or RRETAWA motif could be categorized into 
four main groups. Each group showed possible homologies 
to sequences present in the 9th and 10th type III repeats  of 
fibronectin (Table II).  The homologous sequences occur at 
analogous positions in the two type III repeats. Interestingly, 
all  these  sequences  are  likely  to  reside  in  exposed  loop 
regions based on the known structure of the 10th type III re- 
peat (Main et al., 1992). Only the serine- and phenylalanine- 
containing hydrophobic sequence may locate partially in a/3 
strand. The sequences we identified in this manner in the 9th 
type III repeat could represent the synergistically acting  re- 
gion of fibronectin that has been deduced from site-directed 
mutagenesis  and  antibody  mapping  studies  of fibronectin 
(Obara et al.,  1988;  Aota et al.,  1991; Nagai et al.,  1991). 
These  findings  suggest  a  model of fibronectin interaction 
with ets/~ that is mediated by cumulative binding of several 
loop regions of the type III repeats.  The interaction at the 
RGD loop is undoubtedly the strongest, but the NGR and 
other loops may provide the signal for specific recognition 
of fibronectin by ot5/3~. 
The identification of the *CRRETAWAC* peptide as a high 
affinity  ligand for c~sfl~ was surprising  in that this sequence 
bears no obvious similarity to fibronectin sequences or other 
known ligand sequences for ot5/3~ or other integrins.  Smith 
and colleagues have also described isolation ofpeptides from 
a phage display library that are entirely different from known 
epitopes  for the proteins studied  (Smith and Scott,  1993; 
Smith et al.,  1993).  Because of its divergent sequence, we 
were interested to clarify whether *CRRETAWAC* might in- 
teract with some other site in txs/~ than RGD. Four different 
approaches, phage attachment  assay, fibronectin-binding as- 
say, cell attachment to fibronectin, and cell attachment to the 
*CRRETAWAC*  peptide,  indicated  that  *CRRETAWAC* 
and  RGD  compete  with  each  other  for binding  to  t~sfl~. 
Moreover, the binding of cells to immobilized *CRRETA- 
WAC* peptide was inhibited by EDTA, indicating that the in- 
teraction is divalent cation dependent. However, since the at- 
tachment of RRETAWA-bearing phage was inhibited better 
by the *CRRETAWAC* peptide than by the *CRGDC* pep- 
tide  and the  reverse was true  for the  *CRGDC*-carrying 
phage, it is probable that *CRRETAWAC* does not bind at 
exactly the same site in c~st3t as RGD, but rather at an over- 
lapping site. 
Because we found only one variation of the RRETAWA se- 
quence  among  the  c~5/3~-selected clones  and  because  the 
phage carrying that sequence, RGAPRAW, bound weakly to 
a5/3~, we do  not  know which amino  acids  in  *CRRETA- 
WAC* are important for its activity.  Since this was the only 
high-affinity  sequence isolated, it is possible that the entire 
sequence has to remain invariable.  The combination of posi- 
tive  and  negative  charges  of *CRRETAWAC* is  likely  to 
be important, and the same may be true of the tryptophan 
residue, because tryptophan  was enriched in the RGD pep- 
tides  selected by high-affinity  screening.  In any  event,  the 
*CRRETAWAC* peptide seems to have an appropriate disul- 
fide-dependent conformation to fit in the binding site of u5/3~. 
In conclusion, we have found a novel binding specificity 
in  the  c~5/31 integrin.  Because  of its  selectivity  and  high 
affinity for ct5/3~, the *CRRETAWAC* peptide may be useful 
to discriminate cell adhesion that is mediated by ot5/3~. Im- 
mobilized *CRRETAWAC* peptide can selectively promote 
the attachment of o~5/3~-expressing cells.  Finally,  this work 
illustrates the potential value of phage display libraries  for 
providing information on the possible contact sites between 
a ligand and its receptor. 
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